Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 3496 AL 3510

Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease

Devos D, Lejeune S, Cormier-Dequaire F, Tahiri K, Charbonnier-Beaupel F, Rouaix N, Duhamel A, Sablonnière B, Bonnet AM, Bonnet C, Zahr N, Costentin J, Vidailhet M, Corvol JC.

Parkinsonism Relat Disord. 2014 Feb;20(2):170-5. doi: 10.1016/j.parkreldis.2013.10.017. Epub 2013 Oct 24.

Selective MAO-B inhibitors: a lesson from natural products

Carradori S, D'Ascenzio M, Chimenti P, Secci D, Bolasco A.

Mol Divers. 2014 Feb;18(1):219-43. doi: 10.1007/s11030-013-9490-6. Epub 2013 Nov 12.

Comparison of activities of daily living impairments in Parkinson's disease patients as defined by the Pill Questionnaire and assessments by neurologists

Lee WJ, Chang YY, Lin JJ, Sung YF, Li JY, Wang SJ, Chen RS, Yang YH, Hu CJ, Tsai CH, Wang HC, Wu SL, Chang MH, Fuh JL.

J Neurol Neurosurg Psychiatry. 2014 Sep;85(9):969-73. doi: 10.1136/jnnp-2013-306381. Epub 2013 Nov 11.

Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial

Devos D, Moreau C, Maltête D, Lefaucheur R, Kreisler A, Eusebio A, Defer G, Ouk T, Azulay JP, Krystkowiak P, Witjas T, Delliaux M, Destée A, Duhamel A, Bordet R, Defebvre L, Dujardin K.

J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):668-74. doi: 10.1136/jnnp-2013-306439. Epub 2013 Nov 11.

Clozapine, a fast-off-D2 antipsychotic

Seeman P.

ACS Chem Neurosci. 2014 Jan 15;5(1):24-9. doi: 10.1021/cn400189s. Epub 2013 Nov 18.

Validation of the Italian version of Parkinson's disease-cognitive rating scale (PD-CRS)

Santangelo G, Barone P, Abbruzzese G, Ferini-Strambi L, Antonini A; IRIS Study Group.

Neurol Sci. 2014 Apr;35(4):537-44. doi: 10.1007/s10072-013-1538-y. Epub 2013 Sep 25.

Neuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative disease

Williams CJ, Dexter DT.

J Neurochem. 2014 Apr;129(1):4-20. doi: 10.1111/jnc.12608. Epub 2013 Dec 2.

Paraoxonase 1 in neurological disorders

Menini T, Gugliucci A.

Redox Rep. 2014 Mar;19(2):49-58. doi: 10.1179/1351000213Y.0000000071. Epub 2013 Nov 12.

ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease

Verma M, Steer EK, Chu CT.

Biochim Biophys Acta. 2014 Aug;1842(8):1273-81. doi: 10.1016/j.bbadis.2013.11.005. Epub 2013 Nov 10.

Impact of physical exercise on reaction time in patients with Parkinson's disease-data from the Berlin BIG Study

Ebersbach G, Ebersbach A, Gandor F, Wegner B, Wissel J, Kupsch A.

Arch Phys Med Rehabil. 2014 May;95(5):996-9. doi: 10.1016/j.apmr.2013.10.020. Epub 2013 Nov 11.

Depression and impulse control disorders in Parkinson's disease: two sides of the same coin?

Vriend C, Pattij T, van der Werf YD, Voorn P, Booij J, Rutten S, Berendse HW, van den Heuvel OA.

Neurosci Biobehav Rev. 2014 Jan;38:60-71. doi: 10.1016/j.neubiorev.2013.11.001. Epub 2013 Nov 12.

Neuropathology of cigarette smoking

Chang RC, Ho YS, Wong S, Gentleman SM, Ng HK.

Acta Neuropathol. 2014 Jan;127(1):53-69. doi: 10.1007/s00401-013-1210-x. Epub 2013 Nov 16.

Significant study of population stratification, sensitivity analysis and trim and fill analyses on GBA mutation and Parkinson's disease

Liu J, Zhang HX.

Am J Med Genet B Neuropsychiatr Genet. 2014 Jan;165B(1):96-102. doi: 10.1002/ajmg.b.32214. Epub 2013 Nov 16.

Parkinson syndrome: a precise localization for abducens palsy

Vishnu VY, Petluri G, Gupta V, Lal V, Khurana D, Goyal MK.

J Neurol Sci. 2014 Jan 15;336(1-2):288-9. doi: 10.1016/j.jns.2013.10.045. Epub 2013 Nov 8.

Management of the aging risk factor for Parkinson's disease

Phillipson OT.

Neurobiol Aging. 2014 Apr;35(4):847-57. doi: 10.1016/j.neurobiolaging.2013.10.073. Epub 2013 Oct 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias